Skip to main content
Clinical Trials/NCT00608075
NCT00608075
Unknown
Phase 4

Neurofunctional and Neurochemical Markers of Treatment Response in Bipolar Disorder

University of Cincinnati1 site in 1 country260 target enrollmentApril 2007
InterventionsLithium

Overview

Phase
Phase 4
Intervention
Lithium
Conditions
Bipolar I Disorder
Sponsor
University of Cincinnati
Enrollment
260
Locations
1
Primary Endpoint
The purpose of the research is to study brain structure, function and chemistry of patients with bipolar disorder who are receiving lithium.
Last Updated
9 years ago

Overview

Brief Summary

The purpose of the research is to study brain structure, function and chemistry of patients with bipolar disorder who are receiving lithium, an FDA-approved treatment for bipolar mania, in order to better understand who benefits from treatment and why they respond to medications. Studying this may help improve treatment and outcome in patients with bipolar disorder.

Registry
clinicaltrials.gov
Start Date
April 2007
End Date
July 2017
Last Updated
9 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Caleb M. Adler

Associate Professor

University of Cincinnati

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Arms & Interventions

1

Manic Patients

Intervention: Lithium

2

Depressed Patients

Intervention: Lithium

Outcomes

Primary Outcomes

The purpose of the research is to study brain structure, function and chemistry of patients with bipolar disorder who are receiving lithium.

Time Frame: 8 weeks

Study Sites (1)

Loading locations...

Similar Trials